The Centre has positioned an order to acquire 66 crore extra doses of Covishield and Covaxin to be equipped between August and December this yr, at a revised value of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources mentioned.
They mentioned 37.5 crore of Covishield doses from the Serum Institute of India and 28.5 crore Covaxin doses from Bharat Biotech will probably be procured by December.
“An order to acquire 66 crore extra doses of COVID-19 vaccines–Covishield and Covaxin–to be equipped between August and December, at a revised value of Rs 205 and Rs 215 per dose, respectively, excluding taxes, has been positioned,” the supply mentioned.
The value of every dose of Covishield quantities to Rs 215.25 and Covaxin Rs 225.75, together with taxes, it mentioned.
The Union well being ministry which was procuring each the vaccines at Rs 150 per dose, had indicated that the costs can be revised after the brand new COVID-19 vaccine procurement coverage got here into impact from June 21. Beneath the brand new coverage, the ministry will procure 75 per cent of the vaccines being produced by the drug producers within the nation.
Whereas the Centre has requested each the vaccine manufacturing companies to scale up their manufacturing, the producers had indicated that getting Rs 150 for every dose whereas making investments to ramp up the manufacturing was not viable for them, sources mentioned.
The Union authorities had earlier allowed states and personal hospitals to acquire 50 per cent of the vaccines following calls for for decentralisation of the method.
Nonetheless, after a number of states complained of issues together with of funding, Prime Minister Narendra Modi introduced the revision of the vaccine pointers on June 8.
Home vaccine producers are given the choice to offer 25 per cent of their month-to-month manufacturing of vaccines to non-public hospitals.
In accordance with the revised pointers which got here into impact from June 21, vaccine doses supplied freed from price by the Centre will probably be allotted to states/UTs based mostly on standards corresponding to inhabitants, illness burden and the progress of vaccination, and all above the age of 18 will probably be eligible for the free jabs.
Any wastage of vaccine will have an effect on the allocation negatively.
The states and UTs would mixture the demand of personal hospitals maintaining in view equitable distribution between massive and small non-public hospitals and regional stability.
“Primarily based on this aggregated demand, the Authorities of India will facilitate the provision of those vaccines to the non-public hospitals and their cost by way of the Nationwide Well being Authority’s digital platform. This may allow the smaller and remoter non-public hospitals to acquire a well timed provide of vaccines, and additional equitable entry and regional stability,” the ministry had mentioned.
The value of vaccine doses for personal hospitals can be declared by every vaccine producer, and any subsequent modifications can be notified prematurely, it mentioned.
Greater than 41.69 crore vaccine doses have been supplied to states and UTs thus far, by way of all sources, the well being ministry mentioned on Saturday.